Taking it to the streets. Stockhouse.com: Taking it to the street
Price Change % Change Volume Day High/Low 52 Week High/Low
Last Traded:
Transaction Volume
Open
Prev. Close
Bid
Ask
Bid Size
Ask Size
Market Cap
Shares Out
PE Ratio
Dividend Yield
Advanced Charts
STOCKHOUSE NEWS
Stem Cell Therapeutics reports completion of Phase I study dosing
5/16/2013 3:22:00 PM - Stockhouse Community News by Stockhouse Editorial

Canadian small/micro-cap weekend roundup
2/12/2011 9:32:00 AM - Stockhouse Community News by Stockhouse Editorial Staff

Junior miner up on test results
2/10/2011 4:35:00 PM - Stockhouse Community News by Peter Kennedy

Stockhouse @ the Bell: Stocks up as gridlock looms
10/29/2010 6:37:00 PM - Stockhouse Financial News by Stockhouse Editorial Staff

Stockhouse @ the Bell: Stocks down on mixed earnings
10/28/2010 6:12:00 PM - Stockhouse Financial News by Stockhouse Editorial Staff

Stockhouse @ the Bell: Stocks drop on China concerns
6/29/2010 5:42:00 PM - Stockhouse Financial News by Stockhouse Editorial Staff

Thoughts on Volta's (VTR) resource: Best of the Boards/Blogs
6/29/2010 4:43:00 PM - Stockhouse Community News by Stockhouse Editorial Staff

Stockhouse @ the Bell: Stocks down on economy worries
6/24/2010 5:31:00 PM - Stockhouse Financial News by Stockhouse Editorial Staff

Tiny tech stock an attractive takeover target? Best of the Boards/Blogs
6/24/2010 4:37:00 PM - Stockhouse Community News by Stockhouse Editorial Staff

Stockhouse @ the Bell: U.S. stocks rally on China's Euro pledge
5/27/2010 5:46:00 PM - Stockhouse Financial News by Stockhouse Editorial Staff

NEWS RELEASES
Stem Cell Therapeutics Begins Trading on OTCQX®
5/20/2013 9:04:00 AM - PR Newswire

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace
5/16/2013 7:30:12 AM - Market Wire

Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome
5/16/2013 7:00:36 AM - Market Wire

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
4/17/2013 7:00:25 AM - Marke

Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
4/9/2013 6:32:44 PM - Marke

Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
3/28/2013 7:00:09 AM - Market Wire Canada

Stem Cell Therapeutics Closes $3.1 Million Financing
3/15/2013 9:53:17 AM - Market Wire

Stem Cell Therapeutics Announces Filing of Prospectus Supplement for Proceeds Up to $3.5 Million of Units
3/12/2013 9:30:08 AM - Market Wire

Stem Cell Therapeutics Announces Offering of Up to $3.5 Million of Units
3/7/2013 5:30:03 PM - Market Wire

LATEST BLOG POSTS
subject username date & time rating

Metals Creek Resources Corp(MEK:TSXV... ...
5/22/2013 1:33:22 AM 5

HIGHLIGHTS AND ROUGH VALUATION MBI.V... ...
3/27/2013 11:04:31 AM 3

Gilead Makes $11 Billion Bet on Drug ... ...
11/21/2011 2:45:29 PM 3

The New Tech Bubble, Biotech Vs. Big ... ...
10/30/2011 3:27:31 PM 3

INDIANAPOLIS (AP) -- Cigna Corp. will... ...
10/25/2011 12:09:06 PM 3
LATEST BULLBOARD POSTS
subject username date & time rating

Amended Filing As of 11:59pm ET M...
5/23/2013 3:57:33 PM

...addendas up 182k to his portfolio.
5/23/2013 9:10:38 AM

Last Updated: May 17, 2013Learn more ...
5/18/2013 1:13:20 PM 4

Thought this would be very positive ...
5/18/2013 7:50:34 AM

The most volume in at least 2 years ...
5/17/2013 12:49:18 PM
 
 
 
 
Today's Feature  
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...